MWAM
Manhattan West Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,947
| Closed | -$238K | – | 143 |
|
|
2025
Q1 | $238K | Buy |
29,947
+3,439
| +13% | +$27.3K | 0.06% | 127 |
|
|
2024
Q4 | $257K | Sell |
26,508
-4,103
| -13% | -$39.8K | 0.07% | 120 |
|
|
2024
Q3 | $344K | Buy |
30,611
+3,990
| +15% | +$44.9K | 0.09% | 116 |
|
|
2024
Q2 | $278K | Sell |
26,621
-566
| -2% | -$5.91K | 0.08% | 122 |
|
|
2024
Q1 | $309K | Sell |
27,187
-10,711
| -28% | -$122K | 0.07% | 124 |
|
|
2023
Q4 | $438K | Sell |
37,898
-83,405
| -69% | -$964K | 0.12% | 101 |
|
|
2023
Q3 | $1.11M | Buy |
121,303
+28,987
| +31% | +$266K | 0.34% | 72 |
|
|
2023
Q2 | $1.12M | Buy |
92,316
+27,942
| +43% | +$339K | 0.42% | 69 |
|
|
2023
Q1 | $793K | Buy |
64,374
+9,679
| +18% | +$119K | 0.35% | 76 |
|
|
2022
Q4 | $692K | Sell |
54,695
-864
| -2% | -$10.9K | 0.35% | 74 |
|
|
2022
Q3 | $697K | Buy |
55,559
+4,755
| +9% | +$59.7K | 0.43% | 67 |
|
|
2022
Q2 | $621K | Buy |
50,804
+10,241
| +25% | +$125K | 0.38% | 72 |
|
|
2022
Q1 | $610K | Buy |
+40,563
| New | +$610K | 0.33% | 67 |
|